MS
Insider
Mark E Strome
DirectorMark E Strome (Director) filed 5 Form 4 reports in the trailing twelve months (4 purchases, 1 sale, 3 filed past the two-business-day deadline), most often in ZIVO. Across 4 priced purchase filings, the average 21-session return was +20.4% from execution and +58.0% from disclosure (delay-adjusted; derived). The largest single filing was $895K of BEAT (250,000 sh × $3.58, as filed), executed Dec 17 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+20.4%
avg across 4 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+58.0%
same 4 filings, from disclosure
Filings, ttm
5
4 buys · 1 sells · 3 late
Median delay
6d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.1M
shares × price, as filed
Last traded
Apr 17
Filed Apr 24
Impact on $10,000 · 12M
$17,144 (+71.4%)
S&P 500 $11,725 (+17.2%) · 54.2 pts ahead
Mark E Strome
S&P 500
Compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $2.8M
Sells $895K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
5 filings
Sector per market data · by filing · past 12 months
Most traded names
ZIVO
ZIVO
ZIVO · 4 buys · 0 sells
4 filings
BEAT
BEAT
BEAT · 1 buy · 1 sell
2 filings
Recent filings
ZIVOPURCHASE
Zivo Bioscience, Inc.
View filing →
$200K100,000 sh × $2.00
Exec Apr 17
Filed Apr 24 · 6:16 PM ET † BEATPURCHASE HeartBeam, Inc. View filing → $600K
750,000 sh × $0.80
Exec Apr 16
Filed Apr 16 · 8:46 PM ET ZIVOPURCHASE Zivo Bioscience, Inc. View filing → $195K
20,000 sh × $9.77
Exec Feb 12
Filed Feb 17 · 6:22 AM ET BEATSALE HeartBeam, Inc. View filing → $895K
250,000 sh × $3.58
Exec Dec 17 2025
Filed Dec 22 2025 · 5:30 PM ET † ZIVOPURCHASE Zivo Bioscience, Inc. View filing → $250K
20,259 sh × $12.34
Exec Oct 13 2025
Filed Oct 20 2025 · 4:19 PM ET † ZIVOPURCHASE Zivo Bioscience, Inc. View filing → $1.5M
75,000 sh × $20.19
Exec Dec 26 2024
Filed Dec 31 2024 · 5:30 PM ET †